|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.74 CAD | +0.34% |
|
+1.66% | +15.79% |
| 05-22 | BioSyent Inc., Q1 2026 Earnings Call, May 14, 2026 | |
| 05-19 | BioSyent Secures Health Canada Nod For Hypothyroidism Oral Solution | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 15.06 | 15.8 | 15.79 |
| Spread/Res. | -2.12% | -6.71% | -6.65% |
| Spread/Supp. | +3.00% | +17.92% | +16.98% |
| Support | 14.31 | 12.5 | 12.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- RX Stock
- Charts BioSyent Inc.
Select your edition
All financial news and data tailored to specific country editions
